Established Market Presence InferMed has been delivering clinical decision support solutions since 1999, with over a million monthly user interactions across Europe, North America, and Australasia, indicating a mature and globally recognized platform poised for expansion or upselling opportunities.

Strong Innovation Recognition The company's receipt of the Queen’s Award for Enterprise in Innovation highlights its leadership in healthcare decision support technology, making it an attractive partner for organizations seeking reputable and cutting-edge clinical solutions.

Strategic Acquisition Being acquired by Elsevier, a prominent leader in scientific and medical information, enhances InferMed's credibility and provides access to an extensive network of healthcare and research clients, opening doors for integrated product offerings or contract opportunities.

Sustainable Growth Potential With revenue estimates between $1 million and $10 million and a focused niche in clinical decision support, there is significant potential for business development initiatives aimed at expanding market share within healthcare providers and research institutions.

Key Technology Stack Utilizing established technologies like Debian and OVHcloud, along with Apache-based tools, InferMed has a flexible and scalable technology foundation that can be tailored to meet the needs of potential clients seeking reliable, cloud-enabled clinical decision support systems.